Approval of Kymriah, a new type of Immunotherapy in U.S.

The FDA in U.S. have approved a new type of immunotherapy called Kymriah by Novartis. It’s not a drug but CAR T cell gene therapy. At the moment trials have been successful in a type of leukaemia and its approval is for children and young adults only.

This is a new and very expensive treatment but trials have started happening on solid tumours in U.S. and China. It programmes your immune cells to recognise cancer cells and destroy them so could be a cure in the future. If anyone is interested then google Kymriah. It’s very early days…

Dear Stillhere

Thank you for sharing this news.  I feel sure that many people will find it interesting.

Best wishes
Anna
Digital Community Officer

Stillhere, thankyou for sharing this, a cure in the future, I do hope, I really pray for that.

Evening Still here

Thank you sharing the information with us.
Looks promising. Hopefully a cure for us secondary ladies.

Linda